Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc., announced new findings that show MHC-II protein expression is a more reliable predictor of response to pembrolizumab (Keytruda®) than the ...
SAN DIEGO, Sept. 3, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) today announced the launch of Illumina Protein Prep, an assay introducing superior performance for next-generation sequencing (NGS ...
Integrating high-throughput proteomics into pharmaceutical R&D has shifted how laboratories approach target identification and disease modeling. Mapping complex protein networks provides a functional ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results